1 |
Hillert J, Olerup O. Multiple sclerosis is associated with genes within or close to the HLA DR-DQ subregion on a normal DR115, DQ6, DW2 haplotype. Neurology 1993;43: 163-8
DOI
|
2 |
Rose AS, Ellison GW, Meyers LW, Tourtellotte WW. Criteria for clinical diagnosis of multiple sclerosis. Neurology 1976;26:20-2
DOI
|
3 |
Freedman MS, Thompson EJ, Deisenhammer F, Giovannoni F, Grimsley G, Keir G, et al. Recommended standard of cerebrospinal fluid analysis in the diagnosis of multiple sclerosis. Arch Neurol 2005;62:865-70
DOI
ScienceOn
|
4 |
Adams AB, Tyor WR, Holden KR. Interferon beta-1b and childhood multiple sclerosis. Pediatr Neurol 1999;21:481-3
DOI
ScienceOn
|
5 |
Ross C, Clemmesen KM, Svenson M, Sorensen PS, Koch-Henriksen N, Skovgaard GL, et al. Immunogenicity of interferon- in multiple sclerosis patients: influence of preparation,dosage, dose frequency and route of administration. Ann Neurol 2000;48:706-12
DOI
ScienceOn
|
6 |
Godoth N. Multiple sclerosis in children. Brain Dev 2003;25:229-32
DOI
ScienceOn
|
7 |
Lampert PW. Autoimmune and virus induced demyelinating disease. Am J Pathol 1978;91:176-97
|
8 |
Poser CM, Party DW, Scheinberg L, Mcdonald WI, Davis FA, Ebers GC, et al. New diagnostic criteria for multiple sclerosis; guidelines for research protocols. Ann Neurol 1983;13:227-31
DOI
ScienceOn
|
9 |
Smith ME, Eller NL, McFarland HF, Racke MK, Raine CS. Age depedence of clinical and pathological manifestation of autoimmune demylination. Implications for multiple sclerosis. Am J Pathol 1999;155:1147-61
DOI
ScienceOn
|
10 |
McDonald WI, Compston A, Edan G, Goodkin D, Hartung HP, Lublin FD, et al. Recommended diagnostic criteria for multiple sclerosis: guidelines from the Hnternational Panel on the diagnosis of multiple sclerosis. Ann Neurol 2001;50: 121-7
DOI
ScienceOn
|
11 |
Kupersmith MJ, Kaufmann D, Paty DW, Ebers G, Mcfarland H, Johnson K, et al. Megadose corticosteroids in multiple sclerosis. Neurology 1994;44:1-4
DOI
ScienceOn
|
12 |
Kesslring J, Miller DH, Robb SA, Kendall BE, Moseley IF, Kingsley D, et al. Acute disseminated encephalomyelitis; MRI findings and distinction from multiple sclerosis. Brain 1990;113:291-302
DOI
ScienceOn
|
13 |
Ozakbas S, Idiman E, Baklan B, Yulug B. Childhood and juvenile onset multiple sclerosis: clinical and paraclinical features. Brain Dev 2003;25:233-6
DOI
ScienceOn
|
14 |
Dale RC, de Sousa C, Chong WK, Cox TC, Harding B, Neville BG. Acute disseminated encephalomyelitis and multiple sclerosis in children. Brain 2000;123:2407-22
DOI
ScienceOn
|
15 |
Mikaeloff Y, Moreau T, Debouverie M, Pelletier J, Lebrun C, Gout O, et al. Interferon- treatment in paitents with childhood-onset multiple sclerosis. J Pediatr 2001;139:443-6
DOI
ScienceOn
|
16 |
Kaye EM, vander Knaop MS. Disorders primarily of white matter. In: Swaiman KF, editor. Pediatric Neurology: principles & practice. 4th ed. Volume 2, Philadelphia: Mosby, 2006:1346-72
|
17 |
Barnes MP, Bateman DE, Cleland PG, Dick DJ, Walls TJ, Newman PK, et al. Intravenous methylprednisolone for multiple sclerosis in relapse. J Neurol Neurosurg Psychiatry 1985;48:157-9
DOI
|